CAR T-Cell Therapy Market Size, Outlook, Share, Prominent Players, Growth, and Forecast 2031

Author : Neeraj Kumar | Published On : 24 Apr 2024

The global CAR T-Cell Therapy Market is projected to reach more than USD 22.2 billion by 2032 from USD 2.1 billion in 2023, growing at a CAGR of 30% from 2024-2032.

The global CAR T-Cell Therapy Market is experiencing extraordinary demand, fueled by revolutionary results in treating certain blood cancers. As of 2022, the more than 487,294 people were diagnosed with leukemia around the world. The boom was caused by three things: increasing cancer rates, CAR-T’s clinical success (it cures 80% of some leukemias), and the hundreds of CAR-T clinical trials being run around the world. CAR-T therapies have had the most success so far targeting B-cell CD19 antigens (which is why Kymriah and Yescarta exist). But researchers are hunting down a range of other antigens in a wide variety of cancers.

In addition, they’re also looking at how to treat solid tumors with CAR-T cells. There are still many hurdles to overcome. The cost — over $450,000 per treatment — limits accessibility, as does the complexity of their manufacture. Severe side effects like cytokine release syndrome (CRS) and neurotoxicity are also acting as a solid barrier for the market growth.

A Request of this Sample PDF File@-

Key Players in Global CAR T-Cell Therapy Market

  • Novartis AG
  • Bluebird Bio, Inc.
  • Cellectis
  • Bristol-Myers Squibb
  • Merck & Co., Inc.
  • Juno Therapeutics, Inc.
  • Celyad Oncology
  • Celgene Corporation
  • Sorrento Therapeutics, Inc.
  • Miltenyi Biotech
  • Intellia Therapeutics
  • Pfizer, Inc.
  • Autolus Therapeutics
  • Gilead Sciences, Inc. (Kite Pharma Inc.)
  • Cartesian Therapeutics, Inc.
  • Caribou Biosciences, Inc.
  • Other Prominent Players

Market Overview 

This report offers a meticulously researched evaluation of the market, emphasizing the strategic insights that enterprises need to navigate the competitive environment effectively. The study includes a detailed market valuation that quantifies the market's worth, helping stakeholders understand the financial dimensions and potential growth opportunities. 

Market Dynamics 

The global CAR T-Cell Therapy Market report identifies several key drivers that are propelling market growth, which include technological advancements, shifts in consumer preferences, and regulatory changes across various industries. It also highlights emerging trends that are shaping the industry, providing businesses with the knowledge to stay ahead of the curve. 

Regional Insights 

The global CAR T-Cell Therapy Market report provides in-depth insights into various regional markets, presenting a granular analysis of local trends, economic shifts, and cultural influences that affect market dynamics. This regional analysis ensures that businesses can tailor their strategies to fit different geographic locales, maximizing their market reach and efficacy. 

For Purchase Enquiry:

Segmentation Outlook? 

The global CAR T-Cell Therapy Market report segmentation insights break down the market into manageable segments based on type, application, and geography, allowing businesses to focus their efforts on the most relevant and profitable areas. 

About Astute Analytica:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

Get in touch with us

Phone number: +18884296757

Visit our website

LinkedIn | Twitter | YouTube | Facebook | Pinterest